- Home
- AVBP vs RDFN Comparison
AVBP vs RDFN Comparison
Compare AVBP & RDFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- RDFN
- Stock Information
- Founded
- AVBP 2021
- RDFN 2002
- Country
- AVBP United States
- RDFN United States
- Employees
- AVBP N/A
- RDFN N/A
- Industry
- AVBP
- RDFN Real Estate
- Sector
- AVBP
- RDFN Finance
- Exchange
- AVBP NYSE
- RDFN Nasdaq
- Market Cap
- AVBP 862.8M
- RDFN 1.3B
- IPO Year
- AVBP 2024
- RDFN 2017
- Fundamental
- Price
- AVBP $21.10
- RDFN $11.19
- Analyst Decision
- AVBP Strong Buy
- RDFN Hold
- Analyst Count
- AVBP 8
- RDFN 11
- Target Price
- AVBP $39.00
- RDFN $10.85
- AVG Volume (30 Days)
- AVBP 467.2K
- RDFN 7.9M
- Earning Date
- AVBP 08-13-2025
- RDFN 08-05-2025
- Dividend Yield
- AVBP N/A
- RDFN N/A
- EPS Growth
- AVBP N/A
- RDFN N/A
- EPS
- AVBP N/A
- RDFN N/A
- Revenue
- AVBP N/A
- RDFN $1,038,527,000.00
- Revenue This Year
- AVBP $85.82
- RDFN N/A
- Revenue Next Year
- AVBP N/A
- RDFN $5.32
- P/E Ratio
- AVBP N/A
- RDFN N/A
- Revenue Growth
- AVBP N/A
- RDFN 5.11
- 52 Week Low
- AVBP $15.47
- RDFN $5.49
- 52 Week High
- AVBP $36.37
- RDFN $15.29
- Technical
- Relative Strength Index (RSI)
- AVBP 41.28
- RDFN 58.71
- Support Level
- AVBP $22.12
- RDFN $11.00
- Resistance Level
- AVBP $23.27
- RDFN $11.45
- Average True Range (ATR)
- AVBP 1.50
- RDFN 0.44
- MACD
- AVBP -0.47
- RDFN 0.00
- Stochastic Oscillator
- AVBP 18.97
- RDFN 58.06
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About RDFN Redfin Corporation
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments real estate services, rentals, mortgage, title, and monetization. The company generates the majority of its revenue from Real estate services.